Clinical Trials in Allergy and Immunology in London
London Allergy and Immunology Centre offers consultant-led support for allergy and immunology clinical trials in London, with expertise across Phase 1, Phase 2 and Phase 3 studies in paediatric and adult allergy, immunology, asthma and dermatology.
Consultant-led allergy and immunology research support
Our consultants provide specialist input for sponsors, CROs and research partners seeking a London site with experience in allergic disease, immune-mediated conditions, severe asthma, dermatology and related translational research programmes.
Clinical research in allergy and immunology is evolving rapidly, with increasing focus on biologics, targeted therapies, biomarker-driven stratification, precision medicine and patient-centred study design. This makes specialist investigator oversight, high-quality phenotyping and robust safety monitoring especially important in modern allergy trials.
We are ready to discuss single-site and multi-centre research proposals, including collaborations with established partner networks in the UK and internationally. Our aim is to support clinically meaningful, well-governed research that helps improve outcomes for patients with allergic and immunological disease.
What we can support
- Feasibility review and study start-up planning
- Protocol review and specialist clinical input
- Ethics and MHRA submission support
- Participant identification and recruitment strategy
- Adult and paediatric allergy and immunology research
- Collaboration with specialist partner facilities where required
Clinical trials in allergy and immunology in London with consultant-led support, specialist recruitment pathways and partner research facilities. Laboratory research supporting clinical trials in allergy and immunology at London Allergy and Immunology Centre.
Phase 1–3 trial capability
We can support early- and later-phase studies in allergy and immunology, including programmes requiring careful participant selection, close safety oversight and disease-specific clinical expertise.
End-to-end study set-up
Our team can assist with feasibility assessment, protocol development, ethics submissions, MHRA submissions, site documentation and operational planning for trial delivery.
Specialist recruitment pathways
Dedicated recruitment support helps identify suitable participants with the target condition, while research pharmacy and laboratory pathways can be aligned to protocol-specific requirements.
Clinical research leadership
Clinical research at London Allergy and Immunology Centre is led by Professor Michael Rudenko, an experienced Principal Investigator and Co-Investigator in allergy and immunology clinical trials. Professor Rudenko has contributed to Phase 1–3 studies across a range of allergic and immune-mediated conditions, including severe asthma, urticaria, food allergy and immunotherapy research. His work focuses on rigorous study design, accurate patient phenotyping and adherence to Good Clinical Practice, ensuring high-quality data generation and patient safety. Under his leadership, the centre supports both commercial and academic trials, working closely with sponsors and CROs to deliver efficient study set-up, recruitment and execution in line with current UK regulatory frameworks and evolving standards in precision medicine.
Therapeutic areas relevant to modern allergy and immunology trials
Current allergy and immunology trial programmes increasingly focus on precision medicine, endotype-driven care and targeted treatments. Within this landscape, sponsors commonly seek specialist sites with experience relevant to severe asthma, atopic dermatitis, food allergy, chronic urticaria, angioedema and broader immune-mediated disease.
Allergy and asthma
Studies may include allergic rhinitis, severe asthma, food allergy, drug allergy, urticaria, angioedema and challenge-based assessments where clinically appropriate and supported by the protocol.
Immunology and dermatology
Research may involve immune dysregulation, targeted biologic pathways, atopic dermatitis and related inflammatory conditions that benefit from specialist clinical review and phenotype-led recruitment.
Research governance, quality and patient safety
We recognise that successful commercial and academic trials depend on robust governance, efficient study start-up and consistent Good Clinical Practice standards. Our research approach is designed to support protocol adherence, participant safety, accurate data capture and clear communication between sponsor, site and partner services.
Where a protocol requires access to specialist infrastructure, we work with partner facilities equipped for biomedical research and adjusted to the practical demands of the study. Depending on study design, this may include support for food and drug challenges, close cardiorespiratory observation or overnight monitoring pathways.
- GCP-aligned research activity and ethical conduct
- Specialist allergy and immunology clinical oversight
- Partner facility access for protocol-specific procedures
- Research pharmacy and laboratory support tailored to trial needs
- Clear focus on participant safety, data quality and regulatory readiness
Why choose a specialist London allergy research site?
For sponsors and CROs, specialist disease expertise can improve feasibility, recruitment precision and clinical relevance. In allergy and immunology, careful participant phenotyping is often essential because treatment response may depend on biomarkers, disease subtype, trigger profile and comorbid atopic disease.
Our London location supports access to a diverse population and a broad referral base, helping to strengthen recruitment potential for both adult and paediatric studies.
We welcome enquiries from pharmaceutical companies, biotech organisations, CROs and collaborative academic groups.
Discuss your allergy or immunology clinical trial in London
Research and development remains a priority for our centre, and we are keen to support well-designed projects that advance patient care in allergy and immunology. If you are exploring a new study in London, we would be pleased to review the proposal, discuss feasibility and consider the most appropriate delivery model for your trial.